Metastatic Triple-Negative Breast Carcinoma research hub

Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment

This study looks at whether a digital health platform called CUREETY TECHCARE can improve the lives of people with a type of breast cancer called metastatic triple-negative breast cancer. It compares patients using the platform with those receiving standard care.